Influence of vein valves in the development of arteriosclerosis in venoarterial grafts in the rabbit  Aurelio Chaux, MDa (by invitation), Xin Min Ruan,

Slides:



Advertisements
Similar presentations
Development and regression of intimal thickening of arterially transplanted autologous vein grafts in dogs  Kazumasa Morinaga, M.D., Hiroshi Eguchi, M.D.,
Advertisements

Nondissecting aneurysm of the thoracic aorta with arteritis in systemic lupus erythematosus  Hisato Takagi, MD, PhDa, Yoshio Mori, MD, PhDa, Hisashi Iwata,
Pathology Of Explanted Cryopreserved Allograft Heart Valves: Comparison With Aortic Valves From Orthotopic Heart Transplants  Richard N. Mitchell, MD,
Expression of molecular mediators of apoptosis and their role in the pathogenesis of lower-extremity varicose veins  Enrico Ascher, MD, Theresa Jacob,
Wound healing around and within saphenous vein bypass grafts
A detailed histologic analysis of pulmonary arteriovenous malformations in children with cyanotic congenital heart disease  Brian W. Duncan, MDa, James.
Fariba Chalajour, MD, Laura A
Mesothelium regeneration on acellular bovine pericardia loaded with an angiogenic agent (ginsenoside Rg1) successfully reduces postsurgical pericardial.
Renal vein injury complicating removal of intravenous leiomyoma
Infection of vascular prostheses caused by bacterial biofilms
Nodular pulmonary amyloidosis
Mark Wengrovitz, MD. , Lulseged G. Selassie, MD. , Robert R. M
Intimal-type primary sarcoma of the thoracic aorta presenting as a saccular false aneurysm: Report of a case with evidence of rhabdomyosarcomatous differentiation 
Vein adaptation to arterialization in an experimental model
Behavior of vital and killed autologous pericardium in the descending aorta of sheep  David T. Cheung, PhD, Suk Jung Choo, MD, Albert C. Grobe, MS, Douglas.
Sarcomatous mesothelioma in the left ventricle: A rare entity
Howard P. Greisler, MD, Joan Ellinger, Scott C. Henderson, Anne M
Alex Westerband, MD, Joseph L. Mills, MD, John M. Marek, MD, Ronald L
First human transplantation of a bioengineered airway tissue
Intrapulmonary benign fibrous tumor of the pleura
Improved myocardial protection in minimally invasive aortic valve surgery with the assistance of port-access technology  Shubjeet Kaur, MDa, Jorge Balaguer,
The pathology of fresh and cryopreserved homograft heart valves: An analysis of forty explanted homograft valves  David R. Koolbergen, MD, Mark G. Hazekamp,
Allograft heart valves: The role of apoptosis-mediated cell loss
Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: Clinical relevance to the ross procedure 
The coronary delivery of marrow stromal cells for myocardial regeneration: Pathophysiologic and therapeutic implications  Jih-Shiuan Wang, MD, Dominique.
Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to- baboon orthotopic cardiac xenograft model  He Xu, MDa, Steven R. Gundry,
Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype  Hector F. Simosa, MD, Grace Wang, MD, XinXin Sui,
Comparison of cell-type-specific vs transmural aortic gene expression in experimental aneurysms  Eiketsu Sho, MD, PhD, Mien Sho, MD, Hiroshi Nanjo, MD,
Mark F Berry, MD, Y.Joseph Woo, MD  The Annals of Thoracic Surgery 
Martin H. Chamberlain, FRCS, David P. Taggart, MD, FRCS 
The prognostic significance of tumor cell detection in intraoperative pleural lavage and lung tissue cultures for patients with lung cancer  J. Buhr,
Local treatment with recombinant tissue factor pathway inhibitor reduces the development of intimal hyperplasia in experimental vein grafts  Tam T.T.
The temporal relationship between the development of vein graft intimal hyperplasia and growth factor gene expression  John R. Hoch, MD, Vida K. Stark,
Marcel Scheinman, MD, Enrico Ascher, MD, Gabriel S
The correlation between tumor size and lymphatic vessel invasion in resected peripheral stage I non-small-cell lung cancer  Yukito Ichinose, MDa, Tokujiro.
Construction of a bioengineered cardiac graft
Occult active giant cell aortitis necessitating surgical repair
Inhibitory effect of methylene blue-induced photooxidation on intimal thickening of vein graft  Ke-Xiang Liu, MD, Fumio Yamamoto, MD, Satoshi Sekine,
Aortic wall cell proliferation via basic fibroblast growth factor gene transfer limits progression of experimental abdominal aortic aneurysm  Katsuyuki.
Clifford M. Sales, MD, Michael L. Marin, MD, Frank J
Pathologic features of cryopreserved aortic allograft implanted in the active infection  Akitoshi Yamada, MD, Kenji Okada, MD, Rei Takahashi, MD, Yutaka.
Thrombolysis for experimental deep venous thrombosis maintains valvular competence and vasoreactivity  Jeffrey M. Rhodes, MD, Jae-Sung Cho, MD, Peter.
Glenn C. Hunter, MD, Stephen H. Smyth, MD, Marie L. Aguirre, MD, B
Cerebral hyperthermia during cardiopulmonary bypass in adults
Immunolocalization and temporal distribution of cytokine expression during the development of vein graft intimal hyperplasia in an experimental model 
Cellular therapy reverses myocardial dysfunction
Impact of endothelial cell seeding on long-term patency and subendothelial proliferation in a small-caliber highly porous polytetrafluoroethylene graft 
Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy  Patricia.
Hemodynamic unloading leads to regression of pulmonary vascular disease in rats  Stacy B. O'Blenes, MD, MSca, Stefan Fischer, MDb, Brendan McIntyre, BSca,
Julia Humphries, MSc, Catharine L
Murray H. Kown, MDa, Atsushi Yamaguchi, MDa, Christina L
Intraabdominal hemorrhage as a result of segmental mediolytic arteritis of an omental artery: Case report  Dianne M. Heritz, MD *, Jagdish Butany, MD,
Proliferation of smooth muscle cells in acute allograft vascular rejection  Jun Amano, MDa, Shigeru Ishiyama, MDb, Toshiro Nishikawa, MDb, Hiroyuki Tanaka,
Volume 59, Issue 6, Pages (June 2001)
Development of a spontaneously beating vein by cardiomyocyte transplantation in the wall of the inferior vena cava in a rat: A pilot study  Wangde Dai,
Angioscope-assisted occlusion of venous tributaries with prolamine in in situ femoropopliteal bypass: Preliminary results of canine experiments  John.
Zeljko S. Radic, MD, Martin K. O'Donohoe, MB, FRCSI, Lewis B
Immunosuppressive treatment of aortic allografts
Vein interposition cuffs decrease the intimal hyperplastic response of polytetrafluoroethylene bypass grafts  Mark Kissin, MD, Nikhil Kansal, MD, Peter.
Christopher J. Blewett, MD, Robert E. Cilley, MD, H
The adenosine triphosphate–sensitive potassium channel opener nicorandil protects the ischemic rabbit spinal cord  Yutaka Wakamatsu, MDa, Norihiko Shiiya,
An external, oversized, porous polyester stent reduces vein graft neointima formation, cholesterol concentration, and vascular cell adhesion molecule.
Ren-Ke Li, MD, PhD, Richard D. Weisel, MD, Donald A. G
Joseph J. Piotrowski, MD, Glenn C. Hunter, MD, Cleamond D
Short-term dexamethasone treatment inhibits vein graft thickening in hypercholesterolemic ApoE3Leiden transgenic mice  Abbey Schepers, MD, Nuno M.M. Pires,
Critical hand ischemia caused by forearm fibromuscular dysplasia
Quiz Page January 2010 American Journal of Kidney Diseases
Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: An immunohistochemical.
Thomas J. Kirby, MDa (by invitation), Michael J
Marrow stromal cells for cellular cardiomyoplasty: Feasibility and potential clinical advantages  Jih-Shiuan Wang, MDa,b, Dominique Shum-Tim, MDa, Jacques.
Presentation transcript:

Influence of vein valves in the development of arteriosclerosis in venoarterial grafts in the rabbit  Aurelio Chaux, MDa (by invitation), Xin Min Ruan, MDa (by invitation), Michael C. Fishbein, MDb (by invitation), Meenu Sandhu, MSc (by invitation), Jack M. Matloff, MDa  The Journal of Thoracic and Cardiovascular Surgery  Volume 110, Issue 5, Pages 1381-1390 (November 1995) DOI: 10.1016/S0022-5223(95)70061-7 Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 1 A, Cell density (number of cells per square micrometer) was largest at 2 weeks and progressively decreased during the time of the experiment. B, PCNA expression reached a maximum at 2 weeks, and it was minimal or nonexistent thereafter. Nodifference was detected between the two groups. The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 2 Media: Photomicrographs at a standard original magnification of 50× showing progressive increase in medial thicknessof veins with time that occurred in both treatment groups. A, Control; B, 2 weeks; C, 4 weeks; D, 6 weeks, E and F, 8 weeks. Note in E that at 8 weeks the media was sometimes more fibrous andless cellular and, as shown in F, sometimes contained numerous foamy macrophages (asterisks). a, adventitia; m, media. (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 2 Media: Photomicrographs at a standard original magnification of 50× showing progressive increase in medial thicknessof veins with time that occurred in both treatment groups. A, Control; B, 2 weeks; C, 4 weeks; D, 6 weeks, E and F, 8 weeks. Note in E that at 8 weeks the media was sometimes more fibrous andless cellular and, as shown in F, sometimes contained numerous foamy macrophages (asterisks). a, adventitia; m, media. (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 2 Media: Photomicrographs at a standard original magnification of 50× showing progressive increase in medial thicknessof veins with time that occurred in both treatment groups. A, Control; B, 2 weeks; C, 4 weeks; D, 6 weeks, E and F, 8 weeks. Note in E that at 8 weeks the media was sometimes more fibrous andless cellular and, as shown in F, sometimes contained numerous foamy macrophages (asterisks). a, adventitia; m, media. (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 2 Media: Photomicrographs at a standard original magnification of 50× showing progressive increase in medial thicknessof veins with time that occurred in both treatment groups. A, Control; B, 2 weeks; C, 4 weeks; D, 6 weeks, E and F, 8 weeks. Note in E that at 8 weeks the media was sometimes more fibrous andless cellular and, as shown in F, sometimes contained numerous foamy macrophages (asterisks). a, adventitia; m, media. (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 2 Media: Photomicrographs at a standard original magnification of 50× showing progressive increase in medial thicknessof veins with time that occurred in both treatment groups. A, Control; B, 2 weeks; C, 4 weeks; D, 6 weeks, E and F, 8 weeks. Note in E that at 8 weeks the media was sometimes more fibrous andless cellular and, as shown in F, sometimes contained numerous foamy macrophages (asterisks). a, adventitia; m, media. (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 2 Media: Photomicrographs at a standard original magnification of 50× showing progressive increase in medial thicknessof veins with time that occurred in both treatment groups. A, Control; B, 2 weeks; C, 4 weeks; D, 6 weeks, E and F, 8 weeks. Note in E that at 8 weeks the media was sometimes more fibrous andless cellular and, as shown in F, sometimes contained numerous foamy macrophages (asterisks). a, adventitia; m, media. (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 3 Valve: Photomicrographs demonstrating venous valvular changes. A, B, and C are normal valves (open arrows) at 10×, 25×, and 50× magnification; D, E, and F are valves from veins implanted for 2 to 6 weeks, shown at 10×, 25×, and 50× magnification. Note the marked thickening of the valve base. In E this consistsprimarily of smooth muscle cells. In F foamy macrophages (asterisks) are also present. D, E, and F also demonstrate medial proliferation of the adjacent venous wall (small arrows). (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 3 Valve: Photomicrographs demonstrating venous valvular changes. A, B, and C are normal valves (open arrows) at 10×, 25×, and 50× magnification; D, E, and F are valves from veins implanted for 2 to 6 weeks, shown at 10×, 25×, and 50× magnification. Note the marked thickening of the valve base. In E this consistsprimarily of smooth muscle cells. In F foamy macrophages (asterisks) are also present. D, E, and F also demonstrate medial proliferation of the adjacent venous wall (small arrows). (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 3 Valve: Photomicrographs demonstrating venous valvular changes. A, B, and C are normal valves (open arrows) at 10×, 25×, and 50× magnification; D, E, and F are valves from veins implanted for 2 to 6 weeks, shown at 10×, 25×, and 50× magnification. Note the marked thickening of the valve base. In E this consistsprimarily of smooth muscle cells. In F foamy macrophages (asterisks) are also present. D, E, and F also demonstrate medial proliferation of the adjacent venous wall (small arrows). (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 3 Valve: Photomicrographs demonstrating venous valvular changes. A, B, and C are normal valves (open arrows) at 10×, 25×, and 50× magnification; D, E, and F are valves from veins implanted for 2 to 6 weeks, shown at 10×, 25×, and 50× magnification. Note the marked thickening of the valve base. In E this consistsprimarily of smooth muscle cells. In F foamy macrophages (asterisks) are also present. D, E, and F also demonstrate medial proliferation of the adjacent venous wall (small arrows). (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 3 Valve: Photomicrographs demonstrating venous valvular changes. A, B, and C are normal valves (open arrows) at 10×, 25×, and 50× magnification; D, E, and F are valves from veins implanted for 2 to 6 weeks, shown at 10×, 25×, and 50× magnification. Note the marked thickening of the valve base. In E this consistsprimarily of smooth muscle cells. In F foamy macrophages (asterisks) are also present. D, E, and F also demonstrate medial proliferation of the adjacent venous wall (small arrows). (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 3 Valve: Photomicrographs demonstrating venous valvular changes. A, B, and C are normal valves (open arrows) at 10×, 25×, and 50× magnification; D, E, and F are valves from veins implanted for 2 to 6 weeks, shown at 10×, 25×, and 50× magnification. Note the marked thickening of the valve base. In E this consistsprimarily of smooth muscle cells. In F foamy macrophages (asterisks) are also present. D, E, and F also demonstrate medial proliferation of the adjacent venous wall (small arrows). (Hematoxylin and eosin stain.) The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 4 Immunohistochemistry: Photomicrographs showing results of immunohistochemical studies. A, Hematoxylin and eosin stain of valvular proliferation at 3 days (50×). B, PCNA staining showing numerous positive brown-staining cells (arrows). Inset shows positive control consisting of intestinal crypt epithelium (50×). Adjacent media had little PCNA positivity. C, Valve at 4 weeks showing no PCNA positivity. D, Example of vein wall proliferation of cells (PCNA positivity indicated by arrows) observed within the first 2 weeks after implantation (100×). E, An example of staining of the venous wall at 2 weeks for smooth muscle cell(s), specific act inindicating that virtually all the cells are smooth muscle cells (10×). F, a vein at 8 weeks, with primarily foam cells in the wall (hematoxylin and eosin stain, 10×). G, Most foam cells are negative for smooth muscle-specific actin(s) (100×). H, Another vein showing that foam cells stain positively with amacrophage-specific antibody (red), whereas smooth muscle cell(s) fail to stain (100×). The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 4 Immunohistochemistry: Photomicrographs showing results of immunohistochemical studies. A, Hematoxylin and eosin stain of valvular proliferation at 3 days (50×). B, PCNA staining showing numerous positive brown-staining cells (arrows). Inset shows positive control consisting of intestinal crypt epithelium (50×). Adjacent media had little PCNA positivity. C, Valve at 4 weeks showing no PCNA positivity. D, Example of vein wall proliferation of cells (PCNA positivity indicated by arrows) observed within the first 2 weeks after implantation (100×). E, An example of staining of the venous wall at 2 weeks for smooth muscle cell(s), specific act inindicating that virtually all the cells are smooth muscle cells (10×). F, a vein at 8 weeks, with primarily foam cells in the wall (hematoxylin and eosin stain, 10×). G, Most foam cells are negative for smooth muscle-specific actin(s) (100×). H, Another vein showing that foam cells stain positively with amacrophage-specific antibody (red), whereas smooth muscle cell(s) fail to stain (100×). The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 4 Immunohistochemistry: Photomicrographs showing results of immunohistochemical studies. A, Hematoxylin and eosin stain of valvular proliferation at 3 days (50×). B, PCNA staining showing numerous positive brown-staining cells (arrows). Inset shows positive control consisting of intestinal crypt epithelium (50×). Adjacent media had little PCNA positivity. C, Valve at 4 weeks showing no PCNA positivity. D, Example of vein wall proliferation of cells (PCNA positivity indicated by arrows) observed within the first 2 weeks after implantation (100×). E, An example of staining of the venous wall at 2 weeks for smooth muscle cell(s), specific act inindicating that virtually all the cells are smooth muscle cells (10×). F, a vein at 8 weeks, with primarily foam cells in the wall (hematoxylin and eosin stain, 10×). G, Most foam cells are negative for smooth muscle-specific actin(s) (100×). H, Another vein showing that foam cells stain positively with amacrophage-specific antibody (red), whereas smooth muscle cell(s) fail to stain (100×). The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 4 Immunohistochemistry: Photomicrographs showing results of immunohistochemical studies. A, Hematoxylin and eosin stain of valvular proliferation at 3 days (50×). B, PCNA staining showing numerous positive brown-staining cells (arrows). Inset shows positive control consisting of intestinal crypt epithelium (50×). Adjacent media had little PCNA positivity. C, Valve at 4 weeks showing no PCNA positivity. D, Example of vein wall proliferation of cells (PCNA positivity indicated by arrows) observed within the first 2 weeks after implantation (100×). E, An example of staining of the venous wall at 2 weeks for smooth muscle cell(s), specific act inindicating that virtually all the cells are smooth muscle cells (10×). F, a vein at 8 weeks, with primarily foam cells in the wall (hematoxylin and eosin stain, 10×). G, Most foam cells are negative for smooth muscle-specific actin(s) (100×). H, Another vein showing that foam cells stain positively with amacrophage-specific antibody (red), whereas smooth muscle cell(s) fail to stain (100×). The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 4 Immunohistochemistry: Photomicrographs showing results of immunohistochemical studies. A, Hematoxylin and eosin stain of valvular proliferation at 3 days (50×). B, PCNA staining showing numerous positive brown-staining cells (arrows). Inset shows positive control consisting of intestinal crypt epithelium (50×). Adjacent media had little PCNA positivity. C, Valve at 4 weeks showing no PCNA positivity. D, Example of vein wall proliferation of cells (PCNA positivity indicated by arrows) observed within the first 2 weeks after implantation (100×). E, An example of staining of the venous wall at 2 weeks for smooth muscle cell(s), specific act inindicating that virtually all the cells are smooth muscle cells (10×). F, a vein at 8 weeks, with primarily foam cells in the wall (hematoxylin and eosin stain, 10×). G, Most foam cells are negative for smooth muscle-specific actin(s) (100×). H, Another vein showing that foam cells stain positively with amacrophage-specific antibody (red), whereas smooth muscle cell(s) fail to stain (100×). The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 4 Immunohistochemistry: Photomicrographs showing results of immunohistochemical studies. A, Hematoxylin and eosin stain of valvular proliferation at 3 days (50×). B, PCNA staining showing numerous positive brown-staining cells (arrows). Inset shows positive control consisting of intestinal crypt epithelium (50×). Adjacent media had little PCNA positivity. C, Valve at 4 weeks showing no PCNA positivity. D, Example of vein wall proliferation of cells (PCNA positivity indicated by arrows) observed within the first 2 weeks after implantation (100×). E, An example of staining of the venous wall at 2 weeks for smooth muscle cell(s), specific act inindicating that virtually all the cells are smooth muscle cells (10×). F, a vein at 8 weeks, with primarily foam cells in the wall (hematoxylin and eosin stain, 10×). G, Most foam cells are negative for smooth muscle-specific actin(s) (100×). H, Another vein showing that foam cells stain positively with amacrophage-specific antibody (red), whereas smooth muscle cell(s) fail to stain (100×). The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 4 Immunohistochemistry: Photomicrographs showing results of immunohistochemical studies. A, Hematoxylin and eosin stain of valvular proliferation at 3 days (50×). B, PCNA staining showing numerous positive brown-staining cells (arrows). Inset shows positive control consisting of intestinal crypt epithelium (50×). Adjacent media had little PCNA positivity. C, Valve at 4 weeks showing no PCNA positivity. D, Example of vein wall proliferation of cells (PCNA positivity indicated by arrows) observed within the first 2 weeks after implantation (100×). E, An example of staining of the venous wall at 2 weeks for smooth muscle cell(s), specific act inindicating that virtually all the cells are smooth muscle cells (10×). F, a vein at 8 weeks, with primarily foam cells in the wall (hematoxylin and eosin stain, 10×). G, Most foam cells are negative for smooth muscle-specific actin(s) (100×). H, Another vein showing that foam cells stain positively with amacrophage-specific antibody (red), whereas smooth muscle cell(s) fail to stain (100×). The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions

Fig. 4 Immunohistochemistry: Photomicrographs showing results of immunohistochemical studies. A, Hematoxylin and eosin stain of valvular proliferation at 3 days (50×). B, PCNA staining showing numerous positive brown-staining cells (arrows). Inset shows positive control consisting of intestinal crypt epithelium (50×). Adjacent media had little PCNA positivity. C, Valve at 4 weeks showing no PCNA positivity. D, Example of vein wall proliferation of cells (PCNA positivity indicated by arrows) observed within the first 2 weeks after implantation (100×). E, An example of staining of the venous wall at 2 weeks for smooth muscle cell(s), specific act inindicating that virtually all the cells are smooth muscle cells (10×). F, a vein at 8 weeks, with primarily foam cells in the wall (hematoxylin and eosin stain, 10×). G, Most foam cells are negative for smooth muscle-specific actin(s) (100×). H, Another vein showing that foam cells stain positively with amacrophage-specific antibody (red), whereas smooth muscle cell(s) fail to stain (100×). The Journal of Thoracic and Cardiovascular Surgery 1995 110, 1381-1390DOI: (10.1016/S0022-5223(95)70061-7) Copyright © 1995 Mosby, Inc. Terms and Conditions